Resources Contact Us Home
Solid oral dosage form containing an enhancer

Image Number 17 for United States Patent #8119159.

The invention relates to a pharmaceutical composition and oral dosage forms comprising a bisphosphonate in combination with an enhancer to promote absorption of the bisphosphonate at the GIT cell lining. The enhancer is a medium chain fatty acid or a medium chain fatty acid derivative having a carbon chain length of from 6 to 20 carbon atoms. Preferably, the solid oral dosage form is a controlled release dosage form such as a delayed release dosage form.

  Recently Added Patents
Separate matching models based on type of phone associated with a caller
Nonvolatile semiconductor memory device
Double diffused metal oxide semiconductor device and manufacturing method thereof
Modified binding proteins inhibiting the VEGF-A receptor interaction
Emergent information database management system
Biaxially oriented hydrolysis-stable polyester film comprising epoxidized fatty acid derivatives and a chain extender, and process for production thereof and use thereof
Fabricated leaf tea products
  Randomly Featured Patents
Barbecue griddle
Bonus game for gaming machine providing player with deal or no deal options
System and method of operation of dual redundant controllers
Electro-mechanical filter having a plurality of tuning forks
Photosensitive resin composition
Intermediate connector
Miniature auto focus voice coil actuator system
24-sulfoximine vitamin D3 compounds
Progressive power lens
Ultra wide band, differential input/output, high frequency active combiner in an integrated circuit